Agilent Technologies announced this week that it has named Nick Roelofs vice president and general manager of its Life Sciences Solutions Unit. Roelofs will be responsible for product profit and loss of the business group that includes microarrays, liquid chromatographs, microfluidics, mass spectrometers, capillary electrophoresis, and informatics.
He previously served as group operations officer of Bio-Rad Laboratories’ Life Science Group. He has also served as chief operating officer of Stratagene and has held senior positions at Applied Biosystems and Baxter Diagnostics.
Victoria Blaine recently joined Qiagen as director of molecular diagnostic sales. She joined the firm from Abbott Molecular, a division of Abbott Laboratories, where she served as director of sales.
Morrie Ruffin, executive vice-president for emerging companies and business development, has left the Biotechnology Industry Organization to become CEO of consultancy LifeTech Innovations, said Jim Greenwood, president and CEO of BIO.
Ruffin will continue consulting for BIO, said Greenwood.
Alan Eisenberg, BIO's executive vice president for advocacy, operations, and communications, will assume Ruffin's responsibilities. Before joining BIO, Eisenberg served as a senior advisor on health and economics policy when Greenwood was in Congress. He was also a health policy advisor for the Senate Health, Education, Labor and Pensions Subcommittee on Public Health and a legislative assistant for Arizona's Congressman John Shadegg.
Eisenberg holds a Master of Public Policy degree from Harvard University and an MS in finance from George Washington University.